|Genome-wide DNA methylation profiles in progression to in situand invasive carcinoma of the breast with impact on gene transcription and prognosis|
T Fleischer, A Frigessi, KC Johnson, H Edvardsen, N Touleimat, J Klajic, ...
Genome biology 15 (8), 1-13, 2014
|Methylation profiling with a panel of cancer related genes: association with estrogen receptor, TP53 mutation status and expression subtypes in sporadic breast cancer|
JA Rønneberg, T Fleischer, HK Solvang, SH Nordgard, H Edvardsen, ...
Molecular oncology 5 (1), 61-76, 2011
|Aberrant DNA methylation impacts gene expression and prognosis in breast cancer subtypes|
B Győrffy, G Bottai, T Fleischer, G Munkácsy, J Budczies, L Paladini, ...
International journal of cancer 138 (1), 87-97, 2016
|Individual and combined effects of DNA methylation and copy number alterations on miRNA expression in breast tumors|
MR Aure, SK Leivonen, T Fleischer, Q Zhu, J Overgaard, J Alsner, ...
Genome biology 14 (11), 1-20, 2013
|DNA methylation at enhancers identifies distinct breast cancer lineages|
T Fleischer, X Tekpli, A Mathelier, S Wang, D Nebdal, HP Dhakal, ...
Nature Communications 8 (1), 1-14, 2017
|Quantitative DNA methylation analyses reveal stage dependent DNA methylation and association to clinico-pathological factors in breast tumors|
J Klajic, T Fleischer, E Dejeux, H Edvardsen, F Warnberg, I Bukholm, ...
BMC cancer 13 (1), 1-12, 2013
|Genome-wide DNA methylation analyses in lung adenocarcinomas: Association with EGFR, KRAS and TP53 mutation status, gene expression and prognosis|
MM Bjaanæs, T Fleischer, AR Halvorsen, A Daunay, F Busato, S Solberg, ...
Molecular oncology 10 (2), 330-343, 2016
|DNA methylation in ductal carcinoma in situ related with future development of invasive breast cancer|
KC Johnson, DC Koestler, T Fleischer, P Chen, EG Jenson, JD Marotti, ...
Clinical epigenetics 7 (1), 1-12, 2015
|DNA Methylation Status of Key Cell-Cycle Regulators Such as CDKNA2/p16 and CCNA1 Correlates with Treatment Response to Doxorubicin and 5-Fluorouracil in Locally Advanced Breast …|
J Klajic, F Busato, H Edvardsen, N Touleimat, T Fleischer, I Bukholm, ...
Clinical cancer research 20 (24), 6357-6366, 2014
|EGFR gene alterations in a Norwegian cohort of lung cancer patients selected for surgery|
Å Helland, HM Skaug, L Kleinberg, ML Iversen, AK Rud, T Fleischer, ...
Journal of Thoracic Oncology 6 (5), 947-950, 2011
|Integrated analysis of high‐resolution DNA methylation profiles, gene expression, germline genotypes and clinical end points in breast cancer patients|
T Fleischer, H Edvardsen, HK Solvang, C Daviaud, B Naume, ...
International journal of cancer 134 (11), 2615-2625, 2014
|The 5p12 breast cancer susceptibility locus affects MRPS30 expression in estrogen-receptor positive tumors|
DA Quigley, E Fiorito, S Nord, P Van Loo, GG Alnæs, T Fleischer, J Tost, ...
Molecular oncology 8 (2), 273-284, 2014
|Partially methylated domains are hypervariable in breast cancer and fuel widespread CpG island hypermethylation|
AB Brinkman, S Nik-Zainal, F Simmer, F Rodríguez-González, M Smid, ...
Nature communications 10 (1), 1-10, 2019
|A multi‐omic study reveals BTG2 as a reliable prognostic marker for early‐stage non‐small cell lung cancer|
S Shen, R Zhang, Y Guo, E Loehrer, Y Wei, Y Zhu, Q Yuan, S Moran, ...
Molecular oncology 12 (6), 913-924, 2018
|Differential DNA methylation analysis of breast cancer reveals the impact of immune signaling in radiation therapy|
AR Halvorsen, Å Helland, T Fleischer, KM Haug, GI Grenaker Alnæs, ...
International journal of cancer 135 (9), 2085-2095, 2014
|The Longitudinal Transcriptional Response to Neoadjuvant Chemotherapy with and without Bevacizumab in Breast CancerMolecular Response in Bevacizumab-Treated Breast Tumors|
L Silwal-Pandit, S Nord, H von der Lippe Gythfeldt, EK Møller, T Fleischer, ...
Clinical Cancer Research 23 (16), 4662-4670, 2017
|EGLN2 DNA methylation and expression interact with HIF1A to affect survival of early-stage NSCLC|
R Zhang, L Lai, J He, C Chen, D You, W Duan, X Dong, Y Zhu, L Lin, ...
Epigenetics 14 (2), 118-129, 2019
|Serum cytokine levels in breast cancer patients during neoadjuvant treatment with bevacizumab|
S Jabeen, M Zucknick, M Nome, R Dannenfelser, T Fleischer, S Kumar, ...
Oncoimmunology 7 (11), e1457598, 2018
|DNA methylation signature (SAM40) identifies subgroups of the Luminal A breast cancer samples with distinct survival|
T Fleischer, J Klajic, MR Aure, R Louhimo, AV Pladsen, L Ottestad, ...
Oncotarget 8 (1), 1074, 2017
|Crosstalk between microRNA expression and DNA methylation drives the hormone-dependent phenotype of breast cancer|
MR Aure, T Fleischer, S Bjørklund, J Ankill, JA Castro-Mondragon, ...
Genome medicine 13 (1), 1-21, 2021